Highlights
NASDAQ: CBLI       Cleveland Biolabs
Last Price Today's Change   Day's Range   Trading Volume
0.705   -0.005 (0.70%)  0.701 - 0.80  10,100

Overview

 
Avg Volume (4 weeks):94,410
4 Weeks Range:0.50 - 1.19
4 Weeks Price Volatility (%):
29.71%
52 Weeks Range:0.50 - 2.16
52 Weeks Price Volatility (%):
12.35%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

Cleveland BioLabs Inc is a biopharmaceutical company. The company is developing novel approaches to activate the immune system and address serious medical needs. Its proprietary platform of Toll-like immune receptor activators has applications in mitigation of radiation injury and immuno-oncology. Cleveland's lead product candidate is entolimod, an immuno-stimulatory agent, which is developed as a radiation countermeasure and an immunotherapy for oncology and other indications. Entolimod is a Toll-like receptor 5 (TLR5) agonist, which is developed as a radiation countermeasure for prevention of death from Acute Radiation Syndrome (ARS), and as an oncology drug.

  Be the first to like this.
 


 

3995  4101  641  182 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 CELG 108.24+0.11 
 EEM 44.42-0.02 
 SPY 317.32+0.19 
 AMD 41.15-1.44 
 VXX 15.53-0.67 
 DHR 148.52-2.78 
 CHK 0.789+0.006 
 FXI 42.60-0.18 
 GE 11.34-0.10 
 BAC 34.44-0.24 
Partners & Brokers